EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation.

Key topics include:

- Why the UK's medical cannabis framework has barely shifted since legalisation in 2018

- The bottlenecks across cultivation, distribution and clinical access

- How education and reduced stigma are slowly driving patient growth

- What the UK can learn from Germany’s market

- The future: cannabis oils, vape cartridges and engaging the 'cannabis-naive"

Spotify Video Chapters:

00:00 Beyond The Script with Robert Jappie

00:46 Understanding the Regulatory Landscape

02:11 The Four Stages of the Supply Chain

03:37 The 2018 Legislation and Its Impact

05:22 Challenges and Opportunities in the Industry

06:29 Robert's Background and Expertise

08:14 THC Regulations and Industry Struggles

10:31 The Role of Regulators and Compliance

17:28 Supply Chain Improvements and Future Outlook

20:02 Addressing the Cannabis Market

20:22 Releaf's Approach to Medical Cannabis

21:47 Challenges in the UK Cannabis Market

23:24 Building Trust and Patient Advocacy

25:10 Innovative Delivery Methods

29:51 The Dispensary Model and Legalisation

33:39 Lessons from the German Market

36:51 Future Prospects and Legal Challenges

Follow us:

Instagram

TikTok

Twitter

Linkedin

releaf.co.uk